Predicting Nonhemolytic Neonatal Hyperbilirubinemia

被引:33
作者
Norman, Mikael [1 ,4 ]
Aberg, Katarina [2 ]
Holmsten, Karin [5 ]
Weibel, Vania [3 ]
Ekeus, Cecilia [2 ]
机构
[1] Karolinska Inst, Div Pediat, Dept Clin Sci Intervent & Technol, Stockholm, Sweden
[2] Karolinska Inst, Dept Womens & Childrens Hlth, Reprod Hlth, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Obstet & Gynecol, Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Neonatal Med, Stockholm, Sweden
[5] IVF Sweden AB, IVF Clin Umea, Umea, Sweden
关键词
SERUM BILIRUBIN LEVELS; CLINICAL RISK-FACTORS; BODY-MASS INDEX; JAUNDICE; INFANTS; PREVENTION; OUTCOMES; KERNICTERUS; MANAGEMENT; NEWBORNS;
D O I
10.1542/peds.2015-2001
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BACKGROUND: Before hospital discharge, newborn infants should be assessed for the risk of excessive hyperbilirubinemia. We determined maternal and obstetric risk factors for hyperbilirubinemia in infants born at term (gestational age >= 37 weeks) to form an individualized risk assessment tool for clinical use. METHODS: This was a population-based study with data from the Swedish Medical Birth Register from 1999 to 2012, including 1 261 948 singleton infants. Outcome was defined as infants diagnosed with hyperbilirubinemia (N = 23 711), excluding all cases of hemolytic (immunemediated or other specified hemolytic) diseases of the newborn. RESULTS: Risk factors with an adjusted odds ratio (aOR) for neonatal hyperbilirubinemia of >= 1.5 (medium-sized effect or more) were gestational age 37 to 38 weeks (aOR = 2.83), failed vacuum extraction (aOR = 2.79), vacuum extraction (aOR = 2.22), Asian mother (aOR = 2.09), primipara (aOR = 2.06), large-for-gestational-age infant (aOR = 1.84), obese mother (aOR = 1.83), and small-for-gestational-age infant (aOR = 1.66). Planned cesarean delivery (CD) was associated with a reduced risk (aOR = 0.45). Without any of these risk factors (normal birth weight infant delivered vaginally at 39 to 41 weeks' gestation by a non-Asian, nonobese, multiparous mother) the rate of nonhemolytic neonatal hyperbilirubinemia was 0.7%. In relation to the combined load of different risk factors, rates of neonatal hyperbilirubinemia ranged from 0.2% to 25%. CONCLUSIONS: Collection of a few easily available maternal and obstetric risk factors predicts >100-fold variation in the incidence of neonatal hyperbilirubinemia. The information provided herein enables individualized risk prediction with interactions between different risk factors taken into account.
引用
收藏
页码:1087 / 1094
页数:8
相关论文
共 41 条
[1]  
[Anonymous], 2001, J PERINATOL
[2]  
[Anonymous], VARDPROGRAM NEONATAL
[3]  
[Anonymous], 2001, J PERINATOL S1
[4]  
BERK MA, 1989, PEDIATRICS, V83, P1029
[5]   Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants ≥35 weeks gestation [J].
Bhutani, Vinod K. ;
Maisels, M. Jeffrey ;
Stark, Ann R. ;
Buonocore, Giuseppe .
NEONATOLOGY, 2008, 94 (01) :63-67
[6]   Predischarge Screening for Severe Neonatal Hyperbilirubinemia Identifies Infants Who Need Phototherapy [J].
Bhutani, Vinod K. ;
Stark, Ann R. ;
Lazzeroni, Laura C. ;
Poland, Ronald ;
Gourley, Glenn R. ;
Kazmierczak, Steve ;
Meloy, Linda ;
Burgos, Anthony E. ;
Hall, Judith Y. ;
Stevenson, David K. .
JOURNAL OF PEDIATRICS, 2013, 162 (03) :477-+
[7]   National guidelines for treatment of jaundice in the newborn [J].
Bratlid, D. ;
Nakstad, B. ;
Hansen, T. W. R. .
ACTA PAEDIATRICA, 2011, 100 (04) :499-505
[8]   The Biology of Bilirubin Production [J].
Dennery P.A. ;
Weng Y.-H. ;
Stevenson D.K. ;
Yang G. .
Journal of Perinatology, 2001, 21 (Suppl 1) :S17-S20
[9]   Drug therapy: Neonatal hyperbilirubinemia. [J].
Dennery, PA ;
Seidman, DS ;
Stevenson, DK .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (08) :581-590
[10]   Recurrence of kernicterus in term and near-term infants in Denmark [J].
Ebbesen, F .
ACTA PAEDIATRICA, 2000, 89 (10) :1213-1217